Recruiting Crohns Disease Studies in Hamden
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
This is a randomised, double-blind, parallel group, placebo-controlled Phase IIa study designed to evaluate the efficacy and safety of AZD7798 in participants with moderate to severe Crohn's disease....
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with adalimumab or vedolizumab (VDZ) together with ustekinumab (UST) in adults with mode...
About Crohns Disease Clinical Trials in Hamden
Crohn's disease is a chronic inflammatory bowel disease that causes inflammation anywhere in the digestive tract, most commonly in the small intestine and colon. Symptoms include abdominal pain, diarrhea, fatigue, and weight loss. Treatment includes anti-inflammatory drugs, immunosuppressants, biologics, and surgery.
There are currently 2 crohns disease clinical trials recruiting participants in Hamden, CONNECTICUT. These studies are seeking a combined 292 participants. Research is being sponsored by AstraZeneca, Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Crohns Disease Clinical Trials in Hamden — FAQ
Are there crohns disease clinical trials in Hamden?
Yes, there are 2 crohns disease clinical trials currently recruiting in Hamden, CONNECTICUT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hamden?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hamden research site will contact you about next steps.
Are clinical trials in Hamden free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hamden studies also compensate for your time and travel.
What crohns disease treatments are being tested?
The 2 active trials in Hamden are testing new therapies including novel drugs, biologics, and treatment approaches for crohns disease.
Data updated March 2, 2026 from ClinicalTrials.gov